📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease. (2018)

First Author: Pretorius E

Attributed to: Combing biophysical and 'omics methods for understanding the basis of blood clotting and haemostasis, and how to modify it funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0192121

PubMed Identifier: 29494603

Publication URI: http://europepmc.org/abstract/MED/29494603

Type: Journal Article/Review

Volume: 13

Parent Publication: PloS one

Issue: 3

ISSN: 1932-6203